Among older patients with diabetes, metformin was associated with a reduced risk of cancer, but the combination of aspirin and metformin was associated with an increased risk of cancer death.
Statistically nonsignificant reduction in incidence rate of obesity-related cancers seen in Look AHEAD trial.
Using cohorts from 2 large observational studies, researchers investigated whether duration of diabetes and extent of weight loss may be a marker of risk for pancreatic cancer.
Researchers assessed whether adherence to oral antidiabetic medication was a modifiable prognostic factor in patients with CRC and preexisting diabetes.
A study looking at the effect of genetic variations on the pharmacologic activity of metformin found that use of the drug was associated with an increased risk of prostate cancer overall and of high-grade prostate cancer.
Regardless of PSA levels triggering biopsy, no difference in prostate cancer detection at biopsy.
Rates for breast, cervical, colorectal cancer screening lower compared with women without diabetes.
Researchers compared the development of specific CVD risk factors in postmenopausal women who survived breast cancer and women without history of breast cancer.
Standardized incidence ratio highest for prostate cancer for men, nasopharynx cancer for women.
In a review of data from the National Health Interview Survey, researchers identified the relationship between short and long sleep durations and diabetes in cancer survivors.
